Published 3 March 2003. doi:10.1084/jem.20021824
© Rockefeller University Press,
0022-1007/2003/3/669 $5.00
The Journal of Experimental Medicine, Volume 197, Number 5, 669-674
Increased Susceptibility to LPS-induced Endotoxin Shock in Secretory Leukoprotease Inhibitor (SLPI)-deficient Mice
Akira Nakamura1,
Yuriko Mori1,
Koichi Hagiwara1,
Takuji Suzuki1,
Tomohiro Sakakibara1,
Toshiaki Kikuchi1,
Takayuki Igarashi1,
Masahito Ebina1,
Tatsuya Abe1,
Junichi Miyazaki4,
Toshiyuki Takai2,3 and
Toshihiro Nukiwa1
1 Department of Respiratory Oncology and Molecular Medicine, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan
2 Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan
3 Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation (JST)
4 Division of Stem Cell Regulation Research, Osaka University Medical School, Osaka University, Osaka 565-0871, Japan
Address correspondence to Toshihiro Nukiwa, Department of Respiratory Oncology and Molecular Medicine, Institute of Development, Aging and Cancer, Tohoku University 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan. Phone: 81-22-717-8539; Fax: 81-22-717-8549; E-mail: toshinkw{at}idac.tohoku.ac.jp
Secretory leukoprotease inhibitor (SLPI) protects tissue against the destructive action of neutrophil elastase at the site of inflammation. Recent studies on new functions of SLPI have demonstrated that SLPI may play a larger role in innate immunity than merely as a protease inhibitor. To clarify the functions of SLPI in bacterial infections, we generated SLPI-deficient mice (SLPI-/- mice) and analyzed their response to experimental endotoxin shock induced by lipopolysaccharide (LPS). SLPI-/- mice showed a higher mortality from endotoxin shock than did wild type mice. This may be explained in part by our observation that SLPI-/- macro-phages show higher interleukin 6 and high-mobility group (HMG)-1 production and nuclear factor
B activities after LPS treatment than do SLPI+/+ macrophages. SLPI also affects B cell function. SLPI-/- B cells show more proliferation and IgM production after LPS treatment than SLPI+/+ B cells. Our results suggest that SLPI attenuates excessive inflammatory responses and thus assures balanced functioning of innate immunity.
Key Words: endotoxin shock innate immunity LPS NF-
B SLPI

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Jacobsen, L. C., Sorensen, O. E., Cowland, J. B., Borregaard, N., Theilgaard-Monch, K.
(2008). The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of neutrophils, and are coreleased by activated neutrophils. J. Leukoc. Biol.
83: 1155-1164
[Abstract]
[Full Text]
-
Nishimura, J., Saiga, H., Sato, S., Okuyama, M., Kayama, H., Kuwata, H., Matsumoto, S., Nishida, T., Sawa, Y., Akira, S., Yoshikai, Y., Yamamoto, M., Takeda, K.
(2008). Potent Antimycobacterial Activity of Mouse Secretory Leukocyte Protease Inhibitor. J. Immunol.
180: 4032-4039
[Abstract]
[Full Text]
-
Samsom, J. N., van der Marel, A. P. J., van Berkel, L. A., van Helvoort, J. M. L. M., Simons-Oosterhuis, Y., Jansen, W., Greuter, M., Nelissen, R. L. H., Meeuwisse, C. M. L., Nieuwenhuis, E. E. S., Mebius, R. E., Kraal, G.
(2007). Secretory Leukoprotease Inhibitor in Mucosal Lymph Node Dendritic Cells Regulates the Threshold for Mucosal Tolerance. J. Immunol.
179: 6588-6595
[Abstract]
[Full Text]
-
Taggart, C. C., Cryan, S.-A., Weldon, S., Gibbons, A., Greene, C. M., Kelly, E., Low, T. B., O'Neill, S. J., McElvaney, N. G.
(2005). Secretory leucoprotease inhibitor binds to NF-{kappa}B binding sites in monocytes and inhibits p65 binding. JEM
202: 1659-1668
[Abstract]
[Full Text]
-
Iizuka, T., Ishii, Y., Itoh, K., Kiwamoto, T., Kimura, T., Matsuno, Y., Morishima, Y., Hegab, A. E., Homma, S., Nomura, A., Sakamoto, T., Shimura, M., Yoshida, A., Yamamoto, M., Sekizawa, K.
(2005). Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema. GENES CELLS
10: 1113-1125
[Abstract]
[Full Text]
-
Inoue, K.-I., Takano, H., Yanagisawa, R., Sakurai, M., Shimada, A., Yoshino, S., Sato, H., Yoshikawa, T.
(2005). Protective Role of Urinary Trypsin Inhibitor in Acute Lung Injury Induced by Lipopolysaccharide. Exp. Biol. Med.
230: 281-287
[Abstract]
[Full Text]
-
Doumas, S., Kolokotronis, A., Stefanopoulos, P.
(2005). Anti-Inflammatory and Antimicrobial Roles of Secretory Leukocyte Protease Inhibitor. Infect. Immun.
73: 1271-1274
[Full Text]
-
Inoue, K.-I., Takano, H., Shimada, A., Yanagisawa, R., Sakurai, M., Yoshino, S., Sato, H., Yoshikawa, T.
(2005). Urinary Trypsin Inhibitor Protects against Systemic Inflammation Induced by Lipopolysaccharide. Mol. Pharmacol.
67: 673-680
[Abstract]
[Full Text]
-
Schulze, H., Korpal, M., Bergmeier, W., Italiano, J. E. Jr, Wahl, S. M., Shivdasani, R. A.
(2004). Interactions between the megakaryocyte/platelet-specific {beta}1 tubulin and the secretory leukocyte protease inhibitor SLPI suggest a role for regulated proteolysis in platelet functions. Blood
104: 3949-3957
[Abstract]
[Full Text]
-
Malagarie-Cazenave, S., Segui, B., Leveque, S., Garcia, V., Carpentier, S., Altie, M.-F., Brouchet, A., Gouaze, V., Andrieu-Abadie, N., Barreira, Y., Benoist, H., Levade, T.
(2004). Role of FAN in Tumor Necrosis Factor-{alpha} and Lipopolysaccharide-induced Interleukin-6 Secretion and Lethality in D-Galactosamine-sensitized Mice. J. Biol. Chem.
279: 18648-18655
[Abstract]
[Full Text]
-
Kikuchi, T., Kobayashi, T., Gomi, K., Suzuki, T., Tokue, Y., Watanabe, A., Nukiwa, T.
(2004). Dendritic Cells Pulsed with Live and Dead Legionella pneumophila Elicit Distinct Immune Responses. J. Immunol.
172: 1727-1734
[Abstract]
[Full Text]
-
Wang, X., Li, X., Xu, L., Zhan, Y., Yaish-Ohad, S., Erhardt, J. A., Barone, F. C., Feuerstein, G. Z.
(2003). Up-Regulation of Secretory Leukocyte Protease Inhibitor (SLPI) in the Brain after Ischemic Stroke: Adenoviral Expression of SLPI Protects Brain from Ischemic Injury. Mol. Pharmacol.
64: 833-840
[Abstract]
[Full Text]